You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Renal cancer

Tivozanib for treating advanced renal cell carcinoma

  • Technology appraisal guidance
  • Reference number: TA512
  • Published:  21 March 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Final appraisal determination
  2. Draft guidance
  3. Invitation to participate

History

Documents created during the development process.

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 413 KB)

    Published:
    12 February 2018
  • Committee papers (PDF 1.48 MB)

    Published:
    12 February 2018
  • Public committee slides (PDF 411 KB)

    Published:
    12 February 2018

Draft guidance

  • Draft guidance

  • Appraisal consultation document (PDF 403 KB)

    Published:
    11 August 2017
  • Committee papers (PDF 13.95 MB)

    Published:
    11 August 2017
  • Public committee slides (PDF 1.9 MB)

    Published:
    11 August 2017

Invitation to participate

  • Final scope (PDF 226 KB)

    Published:
    09 February 2017
  • Final matrix (PDF 258 KB)

    Published:
    09 February 2017
  • NICE's response to comments on the draft scope and provisional matrix (PDF 199 KB)

    Published:
    09 February 2017
  • Equality impact assessment (Scoping) (PDF 173 KB)

    Published:
    09 February 2017
Back to top